CYPHERPUNK TECHNOLOGIES INC. (CYPH)

↓ Download CSV

CIK 0001509745 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

3.1%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.50M$1.50M
Operating Income-$41.07M-$70.06M-$87.04M-$56.76M-$41.43M-$28.54M-$33.45M-$30.75M-$32.35M-$27.30M
Net Income$4.82M-$67.56M-$81.41M-$54.60M-$40.59M-$27.51M-$32.90M-$23.14M-$29.73M-$25.63M
EPS (Diluted)$0.07$-1.81$-3.98$-4.82$-0.47$-0.63$-1.47$-2.11$-3.31
Total Assets$163.18M$49.12M$72.83M$70.35M$117.91M$54.37M$7.45M$19.07M$29.06M$6.46M
Total Liabilities$9.68M$14.08M$12.68M$11.49M$10.02M$7.72M$9.20M$9.90M$17.95M$36.16M
Shareholders' Equity$153.51M$35.05M$60.14M$58.87M$107.89M$46.65M-$1.75M$9.18M$11.12M-$100.23M
Cash & Equivalents$14.04M$47.25M$70.64M$65.50M$114.92M$52.07M$3.89M$16.28M$25.74M$793.0K
Operating Cash Flow-$43.90M-$60.30M-$43.75M-$49.04M-$35.16M-$25.96M-$26.90M-$26.03M-$22.14M-$25.34M
Capital Expenditures$100.0K$64.0K$144.0K
Shares Outstanding83.85M38.33M25.57M9.90M59.66M59.66M24.19M14.70M12.35M0